
How can tariffs impact healthcare organizations like yours?
Healthcare systems nationwide continue to face mounting financial and operational challenges in the aftermath of the COVID-19 pandemic. Workforce shortages, rising labor costs, and delayed reimbursements remain top concerns for hospital executives.
But beyond these internal pressures, a growing number of external economic forces are now threatening provider sustainability, particularly global healthcare supply chain disruptions driven by trade tariffs.
Even the nation’s largest hospital systems are reporting losses. Mass General Brigham, for example, announced a $72 million shortfall in its 2024 fiscal year.
While revenue cycle management remains a critical internal focus, tariff-related supply constraints may pose an even greater risk to small and mid-sized healthcare providers — especially those that rely on imported pharmaceuticals, devices, and equipment.
As federal trade policy continues to evolve rapidly, healthcare leaders must evaluate how global economic decisions could impact patient care, cost containment, and long-term strategic planning.
Healthcare professionals rely on a broad range of imported medical instruments, pharmaceuticals, and protective equipment to deliver quality care. When inventory shortages occur, patient outcomes suffer and operational costs increase.
Historically, tariffs have been used to limit foreign competition and stimulate domestic manufacturing. A tariff functions as a tax imposed on imported goods. While intended to strengthen national economic interests, these tariffs often lead to increased prices across industries—with downstream effects on healthcare providers and patients.
The U.S. government has implemented tariffs on goods such as steel, aluminum, and now, healthcare equipment and pharmaceutical ingredients. Unlike many consumer products, these materials are foundational to healthcare delivery. Tariffs on essential imports can affect:
Scaling domestic production to meet healthcare demand can take years. In the meantime, price volatility and shortages place additional strain on provider organizations, particularly those in rural, community, and nonprofit hospital settings.
February 1, 2025: Executive order issues 10% tariffs on Chinese imports, and 25% on Canadian and Mexican imports.
February 3, 2025: 30-day pause announced for Canadian and Mexican tariffs; Chinese tariffs remain.
February 10, 2025: Tariffs on steel and aluminum set to increase from 10% to 25% by March 12.
March 4, 2025: Tariffs raised to 25% on Canada and Mexico; 20% on China. Canada and China announce retaliatory tariffs on U.S. goods.
March 12, 2025: Steel and aluminum tariffs go into effect. EU retaliates with trade restrictions.
April 2, 2025: 10% baseline tariff announced on all countries; elevated rates for major trade partners.
April 8, 2025: Warning issued on pending pharmaceutical tariffs.
April 10, 2025: Tariffs on Chinese goods raised to 145%.
While tariffs aim to bolster domestic manufacturing, the U.S. economy has long prioritized services over industrial production. Shifting this balance could take years, requiring:
Healthcare providers across different regions can’t afford to wait. Inaction could result in delayed treatments, revenue disruption, and care delivery bottlenecks.
Tariff volatility creates uncertainty with the healthcare industry’s razor-thin margins, but reducing internal inefficiencies can free up resources and protect margins.
ChartRequest helps healthcare organizations nationwide reduce operational costs through streamlined medical record retrieval, automated invoicing, and digital record exchange processes.
Whether you’re a regional health system in the Southeast or a specialty clinic in the Pacific Northwest, our platform enables providers to redirect staff time from paperwork to patient care.
Explore how ChartRequest supports financial resiliency in uncertain economic conditions across all U.S. markets.